Home
World
U.S.
Politics
Business
Movies
Books
Entertainment
Sports
Living
Travel
Blogs
Kadcyla | search
Overview
Newspapers
Aggregators
Blogs
Videos
Photos
Websites
Click
here
to view Kadcyla news from 60+ newspapers.
Bookmark or Share
Kadcyla Info
Get the latest news about Kadcyla from the top news
sites
,
aggregators
and
blogs
. Also included are
videos
,
photos
, and
websites
related to Kadcyla.
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.
Kadcyla Featured News
FDA approves new targeted breast cancer drug
More
Kadcyla Photos
Kadcyla Websites
Kadcyla: Side Effects, Dosage & Uses - Drugs.com
Kadcyla is used to treat HER2-positive breast cancer. Kadcyla is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic). Kadcyla is usually given after other cancer medications have been tried without success. Kadcyla should not be used in place of Herceptin (trastuzumab). Warnings
Kadcyla | Chemotherapy Drug Information | Chemocare.com
Kadcyla™ is a monoclonal antibody which targets the surface of the cells human epidermal growth factor receptor 2 protein (HER2) on the cancer cell, interfering with HER2 causing cancer cell death. Kadcyla™ incorporates the HER2 targeted actions of trastuzumab with the microtubule inhibitor DM1 (a maytansine derivative).
KADCYLA® (ado-trastuzumab emtansine) in HER2+ Breast Cancer
KADCYLA is a prescription medicine used as an adjuvant (after surgery) treatment for HER2-positive early breast cancer when the patient has taken neoadjuvant (before surgery) treatment including a taxane and trastuzumab (Herceptin ®) and there is cancer remaining in the tissue removed during surgery. Patients are selected for therapy based on an FDA-approved test for KADCYLA.
Trastuzumab emtansine (Kadcyla) - Cancer Research UK
It is also known by its brand name Kadcyla and TDM1. It is a treatment for: • breast cancer that has spread or come back within 6 months of finishing treatment (advanced breast cancer) • early breast cancer, after surgery if there are still some cancer cells left in the lymph nodes or breast. Trastuzumab emtansine is a combination of the drug trastuzumab (also known by its brand name Herceptin) and a drug called emtansine.
Kadcyla: Package Insert / Prescribing Information - Drugs.com
Kadcyla, as a single agent, is indicated for the adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and trastuzumab -based treatment. Select patients for therapy based on an FDA-approved companion diagnostic for Kadcyla [see Dosage and Administration (2.1)].
More
Kadcyla Videos
Kadcyla Topics
Breast Cancer
Cancer
Cancer Drug
Drugs
Fda
Food And Drug Administration
Herceptin
Roche
CNN
»
NEW YORK TIMES
»
FOX NEWS
»
THE ASSOCIATED PRESS
»
WASHINGTON POST
»
AGGREGATORS
GOOGLE NEWS
»
YAHOO NEWS
»
BING NEWS
»
ASK NEWS
»
HUFFINGTON POST
»
TOPIX
»
BBC NEWS
»
MSNBC
»
REUTERS
»
WALL STREET JOURNAL
»
LOS ANGELES TIMES
»
BLOGS
FRIENDFEED
»
WORDPRESS
»
GOOGLE BLOG SEARCH
»
YAHOO BLOG SEARCH
»
TWINGLY BLOG SEARCH
»